[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"food-allergy-in-infants\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:food-allergy-in-infants":27},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,43,76],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":23,"studyType":24,"phases":4,"briefSummary":25,"conditions":26,"keywords":28,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":33,"lastUpdatePostDateStruct":34,"startDateStruct":37,"completionDateStruct":38,"leadSponsor":40,"locationsCount":4},"100634469","oral-immunotherapy-with-egg-in-infants-100634469",false,"NCT07540091","Oral Immunotherapy With Egg in Infants","Oral Immunotherapy With Egg","OIT egg","Inclusion Criteria:\n\n* positive specific IgE to egg\n* positive oral provocation for egg\n* low threshold\n\nExclusion Criteria:\n\n* uncontrolled astham treatment with biologics or immunsupressive drugs treatment with antihistamines","ALL","12 Months","36 Months",{"count":21,"type":22},40,"ESTIMATED","5 Years","OBSERVATIONAL","In children allergic to egg, oral immunotherapy (OIT) with egg may accelerate that the children grow out of the food allergy.\n\nChildren than have a positive oral food provocation with egg with a low threshold, will be offered to start OIT. This means that the child have to ingest a small amount of egg every day.\n\nOnce a year, the child will undergo a new oral food provocation to investigate if the child is still allergic to egg or not.\n\nThe age of the children at time of this acquired tolerance will be compared with a historical cohort of children with egg allergy.",[27],"Food Allergy in Infants",[29,30,31],"oral immunotherapy","OIT","egg","NOT_YET_RECRUITING","2026-04-16",{"date":35,"type":36},"2026-04-20","ACTUAL",{"date":35,"type":22},{"date":39,"type":22},"2036-12-01",{"name":41,"class":42},"Josefine Gradman","OTHER",{"id":44,"slug":45,"hasResults":11,"nctId":46,"briefTitle":47,"officialTitle":47,"acronym":48,"eligibilityCriteria":49,"healthyVolunteers":50,"sex":51,"minAge":52,"maxAge":53,"enrollmentInfo":54,"targetDuration":4,"studyType":56,"phases":57,"briefSummary":59,"conditions":60,"keywords":4,"overallStatus":65,"whyStopped":4,"lastUpdateSubmitDate":66,"lastUpdatePostDateStruct":67,"startDateStruct":69,"completionDateStruct":71,"leadSponsor":73,"locationsCount":75},"100536140","expecting-mothers-study-of-consumption-or-avoidance-of-peanut-and-egg-100536140","NCT06260956","Expecting Mother's Study of Consumption or Avoidance of Peanut and Egg","ESCAPE","Inclusion Criteria:\n\n• o Subject must be able to understand and provide informed consent.\n\n* English-speaking adults, 18 years or older. (Spanish speaking adults may be included after consent document is translated and Spanish speaking study representatives are available to conduct and answer questions during informed consent process and for study follow up.)\n* Maternal consent must be provided for infants.\n* Pregnant women from the time pregnancy is confirmed until 27 weeks of gestation.\n* Self-reported at time of enrollment:\n\n  * no chronic inflammatory conditions that require long-term systemic immunosuppressive medications in first or second trimester\n  * carrying a fetus with a first-degree relative (i.e., mother, father, full sibling) with any self-reported or physician-diagnosed allergic disease (asthma, allergic rhinitis, atopic dermatitis, or food allergy).\n* Intend to give their infant their own breast milk for more than 3 months.\n* Can confidently say they have eaten PN and egg and have tolerated consumption with no food allergy reactions.\n* Willing to be randomized to consumption or avoidance diet.\n* Uncomplicated pregnancy (no gestational diabetes, no preeclampsia, no hyperemesis gravidarum), self-reported at time of enrollment.\n\nExclusion Criteria:\n\n* Inability or unwillingness of subject to give written informed consent or comply with study protocol.\n* Known history of renal\u002Fliver\u002Fcardiac insufficiency in the mother or infant.\n* Pregnant women with PN or egg allergy.\n* Pregnant women who refuse to eat PN (or peanut products) and\u002For eggs.\n* Physician diagnosed immunodeficiency in the mother or infant.\n* Current, diagnosed, mental illness or current, diagnosed, or self-reported, drug or alcohol abuse that, in the opinion of the investigator, would interfere with the subject's ability to comply with study requirements.\n* Past or current medical problems or findings from medical history that are not listed above, which, in the opinion of the investigator, may pose additional risks to the mother or infant from participation in the study, may interfere with the subject's ability to comply with study requirements or that may impact the quality or interpretation of the data obtained from the study.",true,"FEMALE","18 Years","40 Years",{"count":55,"type":22},500,"INTERVENTIONAL",[58],"NA","Peanut allergy is the most common cause of fatal and near-fatal food-allergic reactions and egg allergy is among the two most common causes of food-induced anaphylaxis. The proposed research will explore the development of sensitization to these food(s) in infants based on maternal consumption or avoidance during pregnancy and breastfeeding.",[61,62,63,27,64],"Allergy and Immunology","Peanut and Nut Allergy","Egg Allergy","Food Allergy Peanut","RECRUITING","2025-08-08",{"date":68,"type":36},"2025-08-13",{"date":70,"type":36},"2025-08-01",{"date":72,"type":22},"2029-09",{"name":74,"class":42},"University of Rochester",1,{"id":77,"slug":78,"hasResults":11,"nctId":79,"briefTitle":80,"officialTitle":81,"acronym":82,"eligibilityCriteria":83,"healthyVolunteers":11,"sex":17,"minAge":4,"maxAge":4,"enrollmentInfo":84,"targetDuration":23,"studyType":24,"phases":4,"briefSummary":86,"conditions":87,"keywords":93,"overallStatus":65,"whyStopped":4,"lastUpdateSubmitDate":95,"lastUpdatePostDateStruct":96,"startDateStruct":98,"completionDateStruct":100,"leadSponsor":102,"locationsCount":75},"100412651","a-registry-for-the-food-allergy-community-100412651","NCT04653324","A Registry for the Food Allergy Community","The FARE Patient Registry: A Registry for the Food Allergy Community","FPR","Inclusion Criteria:\n\n* Individuals with diagnosed food allergy\n\nExclusion Criteria:\n\n* Individuals without food allergy",{"count":85,"type":22},23000,"The FARE Patient Registry will serve as a prospective, observational food allergy reporting system that stores detailed health and other basic information about patients' real-world experiences with food allergies, to encourage open sharing of de-identified data and participation in clinical trials. The FARE Patient Registry intends to make and support scientific discoveries by enabling the food allergy community to participate directly in research.",[88,89,90,91,92,27],"Food Hypersensitivity","Anaphylaxis","Eosinophilic Esophagitis","Food Sensitivity","Food Intolerance",[94],"food allergy","2025-03-10",{"date":97,"type":36},"2025-03-12",{"date":99,"type":36},"2017-08-24",{"date":101,"type":22},"2027-08",{"name":103,"class":42},"Food Allergy Research & Education"]